Sarsasapogenin acetateCAS# 35319-91-6 |
- Tigogenin acetate
Catalog No.:BCN9915
CAS No.:2530-07-6
- Smilagenin acetate
Catalog No.:BCX1512
CAS No.:4947-75-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 35319-91-6 | SDF | Download SDF |
| PubChem ID | 10671591.0 | Appearance | Powder |
| Formula | C29H46O4 | M.Wt | 458.68 |
| Type of Compound | Steroids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16S,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl] acetate | ||
| SMILES | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC(=O)C)C)C)C)OC1 | ||
| Standard InChIKey | LVRAKYNQYKVPIK-ZVTQFVCFSA-N | ||
| Standard InChI | InChI=1S/C29H46O4/c1-17-8-13-29(31-16-17)18(2)26-25(33-29)15-24-22-7-6-20-14-21(32-19(3)30)9-11-27(20,4)23(22)10-12-28(24,26)5/h17-18,20-26H,6-16H2,1-5H3/t17-,18-,20+,21-,22+,23-,24-,25-,26-,27-,28-,29+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Sarsasapogenin acetate Dilution Calculator
Sarsasapogenin acetate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.1802 mL | 10.9008 mL | 21.8017 mL | 43.6034 mL | 54.5042 mL |
| 5 mM | 0.436 mL | 2.1802 mL | 4.3603 mL | 8.7207 mL | 10.9008 mL |
| 10 mM | 0.218 mL | 1.0901 mL | 2.1802 mL | 4.3603 mL | 5.4504 mL |
| 50 mM | 0.0436 mL | 0.218 mL | 0.436 mL | 0.8721 mL | 1.0901 mL |
| 100 mM | 0.0218 mL | 0.109 mL | 0.218 mL | 0.436 mL | 0.545 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Fulvotomentoside A
Catalog No.:BCX1506
CAS No.:150107-44-1
- Tetrahydrodehydrodiconiferyl alcohol
Catalog No.:BCX1505
CAS No.:5234-70-8
- Visamminol-3'-O-glucoside
Catalog No.:BCX1504
CAS No.:2254096-98-3
- Hydroxylinderstrenolide
Catalog No.:BCX1503
CAS No.:20267-92-9
- Regaloside E
Catalog No.:BCX1502
CAS No.:123134-21-4
- Homocapsaicin II
Catalog No.:BCX1501
CAS No.:71240-51-2
- Potentillanoside A
Catalog No.:BCX1500
CAS No.:1309589-79-4
- Swertiaside
Catalog No.:BCX1499
CAS No.:96087-14-8
- Confusarin
Catalog No.:BCX1498
CAS No.:108909-02-0
- Denthyrsinin
Catalog No.:BCX1497
CAS No.:118169-17-8
- 9-epi-6-Methoxygeniposidic acid
Catalog No.:BCX1496
CAS No.:1215178-87-2
- 12β-Acetoxycoccinic acid
Catalog No.:BCX1495
CAS No.:125247-74-7
- 4'-Hydroxyflavone
Catalog No.:BCX1508
CAS No.:4143-63-9
- Isoemetine hydrobromide
Catalog No.:BCX1509
CAS No.:21026-77-7
- Isocoptisine acetate
Catalog No.:BCX1510
CAS No.:30426-66-5
- Lycoramine Hydrobromide
Catalog No.:BCX1511
CAS No.:89505-76-0
- Smilagenin acetate
Catalog No.:BCX1512
CAS No.:4947-75-5
- Rhetsinine
Catalog No.:BCX1513
CAS No.:526-43-2
- Synigrin
Catalog No.:BCX1514
CAS No.:534-69-0
- Paeoniflorgenin
Catalog No.:BCX1515
CAS No.:697300-41-7
- Debenzoylpaeoniflorgenin
Catalog No.:BCX1516
CAS No.:1429403-79-1
- dehydrotomatine
Catalog No.:BCX1517
CAS No.:157604-98-3
- Norfuronol
Catalog No.:BCX1518
CAS No.:19322-27-1
- Resveratrol-4'-O-(6"-galloyl)-β-D-glucopyranoside
Catalog No.:BCX1519
CAS No.:928340-97-0
Revisiting 23-iodospirostanes. New facts and full characterization.[Pubmed:19646458]
Steroids. 2009 Nov;74(12):996-1002.
In addition to a previous report, the reaction of tigogenin acetate with ICl in refluxing CHCl(3) produced the hitherto unknown 23R-iodotigogenin acetate, bearing an axial iodine atom at C-23 and its already reported 23S-epimer. The same treatment of Sarsasapogenin acetate led to a single diasteromer characterized as 23S-iodoSarsasapogenin acetate. A full characterization of the obtained compound including (1)H, (13)C NMR, MS and X-ray diffraction is provided.
The zwitterion (23'E)-(23R,25S)-23-[1-(oxidoiminio)eth-yl]-5beta-spiro-stan-3beta-yl acetate.[Pubmed:21578527]
Acta Crystallogr Sect E Struct Rep Online. 2009 Oct 31;65(Pt 11):o2954-5.
The title steroidal compound, C(31)H(49)NO(5), resulted from the selective oximation of (23R)-23-acetyl-Sarsasapogenin acetate. One- and two-dimensional (1)H and (13)C NMR spectra, as well as IR data, are in agreement with the presence of a ketoxime group at C-23. However, recrystallization in slightly acidic media affords the title compound in the rare zwitterionic oxime form, as a consequence of migration of the hydr-oxy H atom to the N atom in the oxime group. This H atom is clearly detected and its position was refined from X-ray data. The geometry for the C=N(+)(H)-O(-) group features long C=N and short N-O bond lengths compared to non-zwitterionic oximes. The ketoxime is stabilized with the E configuration, avoiding steric hindrance between the oxime O atom and H atom at C-23. The sum of the angles around the oxime N atom is 359.6 degrees , giving a planar configuration for that atom, as expected for sp(2) hybridization.
New bisfuran derivative from sarsasapogenin. An X-ray and NMR analysis.[Pubmed:16199071]
Steroids. 2006 Jan;71(1):12-7.
The new bisfuran derivative, (22S,23S)-22,23-dihydroxy-23,26-epoxyfurostane, was obtained from the known oxidation of Sarsasapogenin acetate with NaNO2/BF3 in 5% aqueous acetic acid. The structure of was established using one and two-dimensional 1H, 13C experiments (DEPT, COSY, HETCOR and HMBC) and the configurations at the newly formed stereogenic centers were established as 22S,23S by an X-ray diffraction analysis. Addition of TiCl4 to bisfuran 5 confirmed that this compound is an intermediate in the rearrangement to 22-oxo-23-spiroketals since it was transformed quantitatively into the latter product. The 23-nitroimino intermediate 2 was isolated from the same reaction and its structure established also by an X-ray diffraction analysis; this compound was further transformed into the 23-nitramine 7 which could find application in functionalization of position 24.
